Characteristics and Prognosis of Moderate or Severe Tricuspid Regurgitation

ConditionTricuspid Valve Disease

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorCentre Hospitalier Universitaire, Amiens

About this trial

The tricuspid valve : its evaluation is relatively difficult in echocardiography and the management of tricuspid valve diseases remains poorly codified.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age >18 ans

inclusion criteria: moderate or severe tricuspid regurgitation

Disqualifiers

None

Trial population

Patients with moderate or severe tricuspid regurgitation.

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

Overall survival

It corresponds to the delay between the diagnostic and the date of death.

Time frame

5 Years

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Centre Hospitalier Universitaire, Amiens

Lead sponsor

Source ClinicalTrials.gov

Apply now